What’s in store for Takeda’s R&D strategies? Get an inside view with this survey by Scrip, which takes a look at Takeda’s progress and plans in the wake of their enormous planned acquisition of Shire in 2019.
Takeda began their new R&D strategy two years ago, and three years of the plan remain.
Find out what Shire will bring to the table in terms of Takeda’s R&D, what their plans are for other partnerships, what’s happening with Takeda’s new rare diseases unit, what to look for in the near-term, and capture insights into their continuing efforts to get planned development up to speed in China.
Takeda began their new R&D strategy two years ago, and three years of the plan remain.
Find out what Shire will bring to the table in terms of Takeda’s R&D, what their plans are for other partnerships, what’s happening with Takeda’s new rare diseases unit, what to look for in the near-term, and capture insights into their continuing efforts to get planned development up to speed in China.
